Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

US and Canada

This page shows the latest US and Canada news and features for those working in and with pharma, biotech and healthcare.

Seattle Genetics claims key US approval for Adcetris

Seattle Genetics claims key US approval for Adcetris

Seattle Genetics claims key US approval for Adcetris. Becomes the first new treatment for advanced Hl in more than 40 years. ... has rights to the drug outside the US and Canada.

Latest news

  • $5.76bn deal puts Merck closer to Eisai and fast-growing Lenvima $5.76bn deal puts Merck closer to Eisai and fast-growing Lenvima

    together. Merck (known as MSD outside the US and Canada) is paying $300m to Eisai - plus more than $5bn in potential milestones - to claim a share of the development and commercialisation ... buy-in and a commitment to studies of AZ’s drug alongside

  • Biogen and AbbVie pull MS drug Zinbryta from the market Biogen and AbbVie pull MS drug Zinbryta from the market

    The drug had been launched to date in the EU, US, Switzerland, Canada and Australia and developed a modest following because it is dosed just once a month by self-administered ... The EMA recommends that doctors should review patients currently treated

  • Merck buys cancer-killing virus firm Viralytics for $394m Merck buys cancer-killing virus firm Viralytics for $394m

    The pharma group - known as MSD outside the US and Canada - has agreed to buy Australian biotech Viralytics and Cavatek (CVA21), the company’s lead virus-based cancer therapy which is ... on the rapid advancement of innovative monotherapy approaches

  • J&J extends its JLABS incubator scheme to Europe J&J extends its JLABS incubator scheme to Europe

    eight sites east and west coasts of US and Canada. ... The 10 JLABS operate alongside four innovation centres centred around academic R&D hotspots in the US, UK and China as part of a global network trying to develop close ties

  • Gilead’s triple HIV drug approval prompts GSK lawsuit Gilead’s triple HIV drug approval prompts GSK lawsuit

    The lawsuit has been submitted in the US and Canada and is seeking to prove that bictegravir infringes on intellectual property held by ViiV for its rival integrase inhibitor Tivicay (dolutegravir), ... ViiV says Biktarvy infringes its US and Canadian

More from news
Approximately 0 fully matching, plus 268 partially matching documents found.

Latest Intelligence

  • A unique ecosystem A unique ecosystem

    Over 150 professionals from Europe and Canada attended the event, which brought together eight clusters with special focus on regenerative medicine - one of the focus areas of Medicen. ... In 2018, Medicen will continue its international dynamics with a

  • Deal Watch February 2017 Deal Watch February 2017

    In addition to the upfront and milestone payments, Immunomedics will receive tiered double digit royalties on global net sales, retains an option to co-promote IMMU-132 in the US and ... First approved in North America in 1989, Zoladex sales in 2016 were

  • 2016: The year when deal-makers took stock? 2016: The year when deal-makers took stock?

    Compounding this was the current political uncertainty following regime change in the US and Brexit, with the latter appearing to encourage caution in deal-making which may well continue into 2017. ... This has provided an opportunity for companies

  • Deal Watch October 2016 Deal Watch October 2016

    $4, 300 royalty. Buyout of collaboration. Respiratory 2015. Actavis US and Canada. ... The biosimilar market is heating up. This month Teva has entered into a US and Canada commercialisation arrangement with South Korea's Celltrion.

  • Deal Watch August 2016 Deal Watch August 2016

    A couple of studies in the US and Canada showed that hostile bids succeed in only 50% of cases. ... even assuming the clinical studies in the US and Europe meet all the target endpoints.

More from intelligence
Approximately 0 fully matching, plus 34 partially matching documents found.

Latest appointments

  • NDA bolsters its senior team NDA bolsters its senior team

    US, Europe, Canada and other markets. ... Her contributions will help propel client strategy and accelerate programmes across the EU and US, as well as result in new intriguing service offerings that enable innovative companies to navigate the

  • Celgene’s president and COO to retire Celgene’s president and COO to retire

    Smith has over 30 years of business strategy experience across a range of therapeutic areas, having previously held senior leadership roles at Biovail in Canada, France, the US and Hong Kong, ... Smith's successor, Curran, joined Celgene in 2013 as the

  • Bayer appoints president of Americas pharma business Bayer appoints president of Americas pharma business

    Bayer appoints president of Americas pharma business. Dr Carsten Brunn to lead operations across the US, Canada, Central and Latin America. ... Bayer has appointed Dr Carsten Brunn as the president of its pharmaceuticals business in the Americas,

  • Vikas Sinha joins Verona as non-executive director Vikas Sinha joins Verona as non-executive director

    Vikas Sinha joins Verona as non-executive director. Brings strong US and financial experience to the UK drug development firm. ... Prior to that he spent 11 years at Bayer, holding roles in the US, Canada, Japan and Germany, latterly as chief financial

  • Merck appoints new North America and China biopharma leaders Merck appoints new North America and China biopharma leaders

    He will be responsible for the Massachusetts-based biopharma business' strategic direction and growth across the US and Canada. ... chief commercial officer for the US.

More from appointments
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest from PMHub

  • Acute leukaemia patients get new online information centre that will help them get the best possible care

    Most importantly, the panel of experts from the UK, Italy, France, Spain, Germany, Canada and the US provides insights into how to get the best from a healthcare team, including what ... Follow us on Twitter: Like us on Facebook:

  • McCann Complete Medical Grows its Manchester Office

    We are a growing employer in the UK and Manchester gives us a much needed additional footprint. ... McCann Complete Medical now has established offices in London, Oxford, Macclesfield, Manchester and Glasgow in the UK; New York, Hackensack, Chicago and

  • AXON Communications

    AXON Communications. AXON, a global healthcare consulting firm, harnesses the diverse expertise of our talented team to help our clients create science-based strategies and drive stakeholder activation. ... AXON serves the healthcare communications needs

  • Only Medics

    Authorities. We successfully recruit on both a contingent and retained basis on permanent positions as well as interim medical assignments. ... Our geographic reach is truly global and although our main focus is the European job market, we also recruit

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Quick links

Infographics

Multimedia